| Item | Cat. No. | Application | Isotype |
| Anti-CD154 [IDEC-131 (Toralizumab)] (MABL-3677) | MABL-3677 | Block, IF | Engineer antibody |
| Anti-CD20 [10F381 (rituximab)] (MABL-3678) | MABL-3678 | FC | Engineer antibody |
| Anti-CD3 epsilon [OKT-3 (muromonab)] (MABL-3682) | MABL-3682 | FC | Engineer antibody |
| Anti-CD25 [YTH 906.9HL (Campath-6)] (MABL-3680) | MABL-3680 | IP, Block, FC | Engineer antibody |
| Anti-CD257 [BAFF (Tabalumab)] (MABL-3681) | MABL-3681 | Functional Studies, IP, Neutralisation, WB, ELISA, FC, IF | Engineer antibody |
| Anti-CD33 [hP67.6 (Gemtuzumab)] (MABL-3683) | MABL-3683 | FC, IF | Engineer antibody |
| Anti-CD4 [CE9.1 (Clenoliximab)] (MABL-3685) | MABL-3685 | SPR, Block, ELISA, FC, IHC | Engineer antibody |
| Anti-CD33 [SGN-33 (Lintuzumab)] (MABL-3684) | MABL-3684 | functional | Engineer antibody |
| Anti-CD4 [MT310] (MABL-3686) | MABL-3686 | Blocking, IHC-P, inhibition, IP, FC, IF | Engineer antibody |
| Anti-CD4 [YNB46.1.8 (Campath-9H)] (MABL-3687) | MABL-3687 | FC, IHC, IHC-Fr | Engineer antibody |
| Anti-CD40L [hu5c8 (Ruplizumab)] (MABL-3688) | MABL-3688 | WB, Block, FC | Engineer antibody |
| Anti-CD41 [7E3 (Abciximab)] (MABL-3689) | MABL-3689 | Block, FC | Engineer antibody |
| Anti-CD49B [GBR500 (Vatelizumab, TMC-2206)] (MABL-3690) | MABL-3690 | therapeutic, Block, ELISA, FC | Engineer antibody |
| Anti-CD52 [Alemtuzumab (Campath-1H)] (MABL-3691) | MABL-3691 | Cytotoxicity Assay, IHC-P, in vivo, WB, ELISA, FC, IHC-Fr | Engineer antibody |
| Anti-CD80 [IDEC-114 (Galiximab)] (MABL-3693) | MABL-3693 | IP, modulate, WB, Block, ELISA, FC, IHC | Engineer antibody |
| Anti-CD52 [YTH 34.5-G2b (Campath-1G)] (MABL-3692) | MABL-3692 | Cytotoxicity Assay, IHC-P, in vivo, WB, ELISA, FC, IHC-Fr | Engineer antibody |
| Anti-CCR2 [MLN1202 (Plozalizumab, hu1D9)] (MABL-3673) | MABL-3673 | therapeutic, Block, FC | Engineer antibody |
| Anti-CCR4 [KW-0761 (Mogamulizumab)] (MABL-3674) | MABL-3674 | deplete | Engineer antibody |
| Anti-IL-2R alpha [Basiliximab] (MABL-3708) | MABL-3708 | WB, Block, FC, IF, IHC | Engineer antibody |
| Anti-IL-5 [SB-240563 (Mepolizumab)] (MABL-3709) | MABL-3709 | therapeutic | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
